Dr. Copplinger

Sigmund H. Hsu, MD, is a board-certified and fellowship-trained neurologist with extensive experience in evaluating and treating neurological disorders in cancer patients. He specializes in primary brain tumors, brain and spinal cord metastases, cancer neurology, and the treatment of chemotherapy neurotoxicity. He’s also an assistant professor in the Vivian L. Smith Department of Neurosurgery at McGovern Medical School at UTHealth Houston. Hsu earned his undergraduate and medical degrees from Warren Alpert Medical School of Brown University in Providence, Rhode Island. He completed his medical internship at the Hospital of Saint Raphael in New Haven, Connecticut, where he was awarded medical intern of the year in 1996. After his residency at New York Presbyterian Weill Cornell Medicine in New York, Hsu completed his fellowship training in neuro-oncology at The University of Texas MD Anderson Cancer Center. Before joining UTHealth Houston, Hsu was on the faculty at MD Anderson, where he served as an assistant professor of neuro-oncology and the neurology residency program director. He is a Brain Tumor Network charter member and has volunteered for several years for Run for the Rose, serving as the medical director from 2005 to 2007. Hsu has presented research at several national conferences, and his work has been published in numerous journals and textbooks. His most recent research is focused on novel therapies for recurrent primary CNS lymphoma, recurrent glioblastoma multiforme, and intralumbar injections for cancer therapy. He has several patents granted and pending for his treatments.

Dr. Jay-Jiguang Zhu is a fellowship-trained, board-certified neurologist with specific expertise in neuro-oncology and neurology. He specializes in treating patients with primary brain tumors and central nervous system (CNS) metastasis. Dr. Zhu earned his medical degree from McGill University in Montreal, Quebec, Canada. He completed his residency training in neurology at Tufts University School of Medicine in Boston, Mass. He subsequently completed his fellowship in neuro­-oncology at Massachusetts General Hospital, Harvard Medical School in Boston. Prior to entering medical school, Dr. Zhu received his doctorate in molecular biology at State University of New York in Buffalo, N.Y., and completed his post-doctoral training in CNS tumorigenesis research at Children’s Hospital, Brigham and Woman’s Hospital, Harvard Medical School. Before joining UT Physicians Neurosciences, Dr. Zhu was on the faculty of Tufts Medical Center and Tufts University School of Medicine where he served as an assistant professor and attending in neurology, hematology and oncology. His many honors and awards include CUSBEA scholar (China and United States Biochemistry Exchange Application), Massachusetts Medical Society Scholarships, the Abby H. Shevitz, M.D. Young Physician award, and Teaching Award from the class of 2002 at Tufts University School of Medicine. Dr. Zhu is dedicated to delivering exceptional patient care through multidisciplinary teamwork. He is committed to providing patients the best treatment options available and to maximizing each patient’s quality of life. Through collaboration with clinicians and research scientists, he will combine clinical data with sophisticated molecular assays and powerful imaging techniques to formulate individualized treatment plans and develop new treatment options for primary brain tumors and CNS metastasis.